BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34500373)

  • 1. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
    Li H; Zhao Q; Tang Z
    Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.
    Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M
    Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.
    Peng BH; Ji YF; Qiu XJ
    J Clin Lab Anal; 2022 Jul; 36(7):e24506. PubMed ID: 35588441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma.
    Wang K; Jin W; Song Y; Fei X
    Mol Cancer; 2017 Oct; 16(1):166. PubMed ID: 29070041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MIR9-3HG enhances LIMK1 mRNA and protein levels to contribute to the carcinogenesis of lung squamous cell carcinoma via sponging miR-138-5p and recruiting TAF15.
    Xiong Y; Yang C; Yang X; Ding C; Wang Q; Zhu H
    Pathol Res Pract; 2022 Sep; 237():153941. PubMed ID: 35933883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis.
    Liu L; Li Y; Zhang R; Li C; Xiong J; Wei Y
    BMC Pulm Med; 2020 Jun; 20(1):163. PubMed ID: 32513149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.
    Lu Y
    Comput Math Methods Med; 2021; 2021():6248793. PubMed ID: 34306176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP.
    Weng L; Qiu K; Gao W; Shi C; Shu F
    BMC Pulm Med; 2020 Aug; 20(1):213. PubMed ID: 32787827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
    Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
    J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC01232 promotes lung squamous cell carcinoma progression through modulating miR-181a-5p/SMAD2 axis.
    Zhang D; Hua M; Zhang N
    Am J Med Sci; 2023 Apr; 365(4):386-395. PubMed ID: 36543302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in lung squamous cell carcinoma.
    Ding J; Huang M; Huang B; Peng X; Wu G; Peng C; Zhang H; Mao C; Wu X
    Environ Mol Mutagen; 2022 Aug; 63(7):351-361. PubMed ID: 36161731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma.
    Yin Z; Ding H; He E; Chen J; Li M
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27704627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis.
    Cheng Z; Jiang S; Tao R; Ge H; Qin J
    Bioengineered; 2022 Feb; 13(2):2114-2129. PubMed ID: 35034547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression.
    Zhao Z; Li H; Li J; Rong Y; Zhao L; Hao M; Tian F
    J Cardiothorac Surg; 2024 Apr; 19(1):222. PubMed ID: 38627774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
    Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
    Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA FOXP4-AS promotes the progression of non-small cell lung cancer by regulating the miR-3184-5p/EIF5A axis.
    Li D; Li Z; YanFei W; Wang Y; Shi J; Liu C; Qu L; Deng S; Xiong D
    J Tissue Eng Regen Med; 2022 Apr; 16(4):335-345. PubMed ID: 34921595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RP11-295G20.2 facilitates hepatocellular carcinoma progression via the miR-6884-3p/CCNB1 pathway.
    Li J; Xia T; Cao J; He D; Chen Z; Liang B; Song J
    Aging (Albany NY); 2020 Jul; 12(14):14918-14932. PubMed ID: 32687483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.
    Ma J; Qi G; Li L
    Cell Mol Biol Lett; 2020; 25():34. PubMed ID: 32514270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer.
    Luo W; Wang J; Xu W; Ma C; Wan F; Huang Y; Yao M; Zhang H; Qu Y; Ye D; Zhu Y
    Cell Death Dis; 2021 Nov; 12(11):1043. PubMed ID: 34728613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism Research of lncRNA miR143HG on Regulating the Biological Behavior 
of Lung Squamous Cell Carcinoma H520 Cells].
    Gou L; He Y; Qiu P; Huang B
    Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):741-752. PubMed ID: 37989337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.